Physician profile
Haritha P Saikumar
NPI 1932544830
$1,361.87
in general payments reported to CMS, 2019-2025
18 companies · $387 in 2025
The $387 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $248 · 2020: $32.95 · 2022: $153 · 2023: $50.30 · 2024: $490 · 2025: $387.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $927.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $927.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $291.93 | 2024-2025 | Nucala, Trelegy Ellipta |
| Astrazeneca Pharmaceuticals LP | $259.46 | 2019-2024 | Airsupra, Breztri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $222.81 | 2019-2025 | Ofev |
| United Therapeutics Corporation | $104.93 | 2024 | Tyvaso |
| Janssen Pharmaceuticals, INC | $64.08 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $59.99 | 2019-2024 | Recarbrio, Dificid, Zerbaxa |
| Regeneron Healthcare Solutions, INC. | $52.46 | 2024-2025 | Dupixent |
| Takeda Pharmaceuticals U.S.A., INC. | $43.61 | 2024-2025 | Cuvitru, Glassia |
| Genzyme Corporation | $40.25 | 2024 | |
| Pfizer INC. | $37.59 | 2019 | |
| Inogen, INC. | $37.55 | 2025 | |
| Insmed, INC. | $31.94 | 2025 | Arikayce |
| Grifols USA, LLC | $26.90 | 2025 | Prolastin-C Liquid |
| Mylan Specialty L.P. | $22.29 | 2024 | Yupelri |
| Electromed, INC. | $19.52 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $17.06 | 2023 | Veklury |
| Chiesi USA, INC. | $15.01 | 2019 | |
| Philips North America LLC | $14.49 | 2024 | (Ak6) Vest Therapy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Haritha Saikumar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.